Home > News > 2nd Annual Pharmaceutical Biotechnology Congress
Industry Updates New Products Supplier News Upcoming Events business web

2nd Annual Pharmaceutical Biotechnology Congress

Hits:1421   Date: 6/1/2018

2nd Annual Pharmaceutical Biotechnology Congress

May 06-07, 2019 ∣ Tokyo, Japan
Theme: Comprehensive Innovations and Researches in Pharmaceutical Biotechnology   
 
Short Name: Pharma Biotech Congress 2019   
 
Conferenceseries LLC proudly announces the commencement of “2nd Annual Pharmaceutical Biotechnology Congress” which is going to be held during May 06-07, 2019 at Tokyo, Japan.
 
Pharma Biotech Congress 2019 focuses upon “Comprehensive Innovations and Researches in Pharmaceutical Biotechnology”.  This Pharma Biotech Congress 2019 focuses on the trends which the biopharmaceutical market is heading on since its launch till the present date and moving on to the projections in future. It takes into its fold the critical developmental procedures, analyses, regulatory factors and also pharmacovigilance including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects towards biosimilars and follow on biologics development and successful launching to the market.
 
Why to attend???
Join your peers around the world focused on learning about Biopharmaceutics, Biologics and Biosimilars related advances, which is your single best opportunity to reach the largest assemblage of participants from the Biopharma community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference.
 
Target Audience:
Biopharma, Biotech, Pharma Industry CEO, Directors, R&D Researchers
Business Entrepreneurs, Training Institutes, Software developing companies,
Medical Devices Manufacturing Companies, CRO
Data Management, Clinical Trial Conducting Organizations and Companies
Students, Scientists, Researchers, and Faculty of Pharmaceutical Sciences
Universities, Medical Colleges, Researchers from Pharmaceutical background
 
Market Analysis
The Global Biopharmaceutical Market is poised to grow at a CAGR of around 10.1% over the next decade to reach approximately $459.81 billion by 2025.The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the Pharma market. It’s by far the fastest-growing part of the industry. Biopharma’s current annual growth rate of more than 8% is double that of conventional Pharma, and growth is expected to continue at that rate for the foreseeable future.
 
It is estimated at USD 215 million for the year 2017 and is projected to reach USD 269 billion by the year 2021. The estimated CAGR during the forecast period (2017-2021) is 5.76%.
 
As the Japanese Pharma economy is in a state of transition towards greater openness, potential rewards for early international movers were cited as another key factor in the rapid shifts predicted in 2018.
 
The pharmaceutical market in Japan is set to rise from around $70 billion in 2016 to $72 billion by 2021, representing a low compound annual growth rate of 0.3%, according to Global Data, a recognized leader in providing business information and analytics.
 
Japan represents the world’s eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed markets such as the United States and Europe.
 
The Japanese government has identified growth of the country’s generic drug market as imperative to Japan’s long-term economic health
 
The penetration of generics has grown robustly over the past few years. The government has also made a target towards achieving a generic penetration of 60% by 2018. This is expected to create huge opportunities for both domestic and foreign generic manufacturers in Japan.
 
The biggest change for Pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Japanese officials proudly say some drug approvals in Japan are now faster than in both Europe and the U.S.—a marked change from the days when Japan was seen as a difficult market for foreign companies.
 
Session/Tracks
·Biopharmaceuticals
·Novel Approaches in Biopharmaceutics
·Nanoparticles in Biopharmaceuticals
·Biotechnology in Health Care
·Formulation of Biotech Products
·Agriculture Biotechnology
·Advances in Biotech Manufacturing
·Biotechnology and its Applications
·Biopharmaceutical Engineering
·Chemical Biotechnology
·Cancer Biology and Immunology
·Industrial and Microbial Biotechnology
·Biopharmaceutical Production in Transgenic Animals
·Development on Recombinant Protein
·Biotech Companies and Market Analysis
·Biotechnological Products
·Biopharmaceutical Pharmacovigilance
·Bioavailability/Bioequivalence on Biopharmaceutical Products
·Clinical Trials on Biopharmaceutical Products
·Drug Disposition & Pharmacokinetics
 
About City
Tokyo is Japan’s capital and the largest metropolitan area in the world. It is also one of Japan’s 47 prefectures, consisting of 23 central city wards and multiple cities, towns and villages west of the city center. The Izu and Ogasawara Islands are also part of Tokyo. Prior to 1868, Tokyo was known as Edo. A small castle town in the 16th century, Edo became Japan’s political center in 1603 when Tokugawa Ieyasu established his feudal government there. A few decades later, Edo had grown into one of the world’s most populous cities. With the Meiji Restoration of 1868, the emperor and capital moved from Kyoto to Edo, which was renamed Tokyo (“Eastern Capital”).
 
World’s highest Skywalk- the Tokyo Sky tree is the tallest free-standing tower in the world, measuring 634m. The observation deck at 450m is the world’s highest skywalk and offers panoramic views of the city.
 
Tokyo is a fascinating city, where the latest trends and the oldest traditions meet. From ancient cherry-blossomfestivals to the vibrant Harajuku neighbourhood, Tokyo offers a seemingly unlimited choice of shopping, entertainment, culture and dining to its visitors.
 
The city’s history can be appreciated in districts such as Asakusa, and in many excellent museums, historic temples and gardens. Contrary to common perception, Tokyo also offers a number of attractive green spaces in the city centre and within relatively short train rides at its outskirts.
 
Drop us an email for Program enquiry.
Pharmabio@pharmaconferenceseries.com 
Sponsors / Exhibiting / Advertising.
Pharmabiotechcongress2018@protonmail.com
General Queries
Pharmabio@pharmaconferenceseries.com